12/17/2024
4:24 PM | Catalyst Pharmaceuticals (Issuer)
Miller Steve (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/11/2024
4:00 PM | Catalyst Pharmaceuticals (Issuer)
Del Carmen Jeffrey (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/11/2024
4:00 PM | Catalyst Pharmaceuticals (Issuer)
Sundaram Preethi (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/11/2024
4:00 PM | Catalyst Pharmaceuticals (Issuer)
DENKHAUS DONALD A (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/11/2024
4:00 PM | Catalyst Pharmaceuticals (Issuer)
O'Keeffe Charles B (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/11/2024
4:00 PM | Catalyst Pharmaceuticals (Issuer)
MCENANY PATRICK J (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/11/2024
4:00 PM | Catalyst Pharmaceuticals (Issuer)
Harper Molly (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
|
12/11/2024
4:00 PM | Catalyst Pharmaceuticals (Issuer)
Elsbernd Brian (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/11/2024
4:00 PM | Catalyst Pharmaceuticals (Issuer)
Tierney David S (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/11/2024
4:00 PM | Catalyst Pharmaceuticals (Issuer)
INGENITO GARY (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/11/2024
4:00 PM | Catalyst Pharmaceuticals (Issuer)
Thompson Tamar (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/11/2024
4:00 PM | Catalyst Pharmaceuticals (Issuer)
Miller Steve (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/10/2024
11:55 AM | Catalyst Pharmaceuticals (Subject)
Miller Steve (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
11/29/2024
7:08 PM | Catalyst Pharmaceuticals (Issuer)
Elsbernd Brian (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/29/2024
7:09 PM | Catalyst Pharmaceuticals (Issuer)
Harper Molly (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/29/2024
7:09 PM | Catalyst Pharmaceuticals (Issuer)
INGENITO GARY (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/27/2024
1:42 PM | Catalyst Pharmaceuticals (Subject)
INGENITO GARY (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
11/27/2024
8:42 AM | Catalyst Pharmaceuticals (Subject)
Harper Molly (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
11/26/2024
11:37 AM | Catalyst Pharmaceuticals (Subject)
Elsbernd Brian (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
11/25/2024
4:00 PM | Catalyst Pharmaceuticals (Issuer)
Elsbernd Brian (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/25/2024
4:00 PM | Catalyst Pharmaceuticals (Issuer)
Thompson Tamar (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/25/2024
4:00 PM | Catalyst Pharmaceuticals (Issuer)
Daly Richard J (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/25/2024
4:00 PM | Catalyst Pharmaceuticals (Issuer)
Harper Molly (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/25/2024
4:01 PM | Catalyst Pharmaceuticals (Issuer)
O'Keeffe Charles B (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/25/2024
4:01 PM | Catalyst Pharmaceuticals (Issuer)
Kalb Michael Wayne (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/25/2024
4:01 PM | Catalyst Pharmaceuticals (Issuer)
INGENITO GARY (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/25/2024
4:01 PM | Catalyst Pharmaceuticals (Issuer)
Tierney David S (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/25/2024
4:01 PM | Catalyst Pharmaceuticals (Issuer)
DENKHAUS DONALD A (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/25/2024
4:01 PM | Catalyst Pharmaceuticals (Issuer)
Miller Steve (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/25/2024
4:01 PM | Catalyst Pharmaceuticals (Issuer)
MCENANY PATRICK J (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/25/2024
4:01 PM | Catalyst Pharmaceuticals (Issuer)
Sundaram Preethi (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/25/2024
4:01 PM | Catalyst Pharmaceuticals (Issuer)
Del Carmen Jeffrey (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/22/2024
4:00 PM | Catalyst Pharmaceuticals (Issuer)
INGENITO GARY (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/21/2024
4:11 PM | Catalyst Pharmaceuticals (Issuer)
MCENANY PATRICK J (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/20/2024
1:57 PM | Catalyst Pharmaceuticals (Subject)
MCENANY PATRICK J (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
11/15/2024
4:00 PM | Catalyst Pharmaceuticals (Issuer)
MCENANY PATRICK J (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/14/2024
8:55 AM | Catalyst Pharmaceuticals (Subject)
Flynn James E (Filed by)
| Form SC 13G/A | |
11/13/2024
4:44 PM | Catalyst Pharmaceuticals (Issuer)
MCENANY PATRICK J (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/12/2024
9:52 AM | Catalyst Pharmaceuticals (Subject)
MCENANY PATRICK J (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
11/06/2024
4:10 PM | Catalyst Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/06/2024
3:08 PM | Catalyst Pharmaceuticals (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
We recommended Palantir in 2021, now we’re recommending this... (Ad) My research indicates there is only one investment that can meet AI's unprecedented demand for energy. Click to get the name and ticker symbol |
10/18/2024
2:31 PM | BlackRock, Inc. (Filed by)
Catalyst Pharmaceuticals (Subject)
| Form SC 13G/A | |
10/17/2024
11:14 AM | Catalyst Pharmaceuticals (Subject)
STATE STREET CORP (Filed by)
| Form SC 13G/A | |
09/26/2024
7:42 AM | Catalyst Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/23/2024
4:00 PM | Catalyst Pharmaceuticals (Issuer)
Tierney David S (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/22/2024
4:00 PM | Catalyst Pharmaceuticals (Issuer)
Miller Steve (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/21/2024
1:21 PM | Catalyst Pharmaceuticals (Subject)
Tierney David S (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
08/20/2024
3:42 PM | Catalyst Pharmaceuticals (Subject)
Miller Steve (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
08/19/2024
4:00 PM | Catalyst Pharmaceuticals (Issuer)
MCENANY PATRICK J (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/09/2024
1:53 PM | Catalyst Pharmaceuticals (Subject)
INGENITO GARY (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
08/09/2024
10:24 AM | Catalyst Pharmaceuticals (Subject)
Del Carmen Jeffrey (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
08/07/2024
3:32 PM | Catalyst Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
07/26/2024
3:30 PM | Catalyst Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/07/2024
10:17 AM | Catalyst Pharmaceuticals (Subject)
Del Carmen Jeffrey (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
06/05/2024
2:22 PM | Catalyst Pharmaceuticals (Subject)
INGENITO GARY (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
06/04/2024
9:41 AM | Catalyst Pharmaceuticals (Subject)
Daly Richard J (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
06/03/2024
11:22 AM | Catalyst Pharmaceuticals (Subject)
Harper Molly (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
05/31/2024
3:50 PM | Catalyst Pharmaceuticals (Filer)
| Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
05/31/2024
3:43 PM | Catalyst Pharmaceuticals (Filer)
| Form POS EX | |
05/31/2024
3:46 PM | Catalyst Pharmaceuticals (Filer)
| Form POS EX | |
05/31/2024
3:47 PM | Catalyst Pharmaceuticals (Filer)
| Form POS EX | |
05/30/2024
3:43 PM | Catalyst Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/21/2024
4:28 PM | Catalyst Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/10/2024
4:15 PM | Catalyst Pharmaceuticals (Issuer)
Tierney David S (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/10/2024
3:23 PM | Catalyst Pharmaceuticals (Filer)
| Form DEF 14A | |
04/10/2024
3:25 PM | Catalyst Pharmaceuticals (Filer)
| Form ARS | |
04/08/2024
1:03 PM | Catalyst Pharmaceuticals (Subject)
Tierney David S (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
03/28/2024
3:45 PM | Catalyst Pharmaceuticals (Issuer)
Elsbernd Brian (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/27/2024
2:01 PM | Catalyst Pharmaceuticals (Subject)
Elsbernd Brian (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
03/13/2024
4:01 PM | Catalyst Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/28/2024
4:16 PM | Catalyst Pharmaceuticals (Filer)
| Form 10-K
Annual report pursuant to Section 13 or 15(d) | |
02/12/2024
4:31 PM | Catalyst Pharmaceuticals (Subject)
Flynn James E (Filed by)
| Form SC 13G/A | |
02/06/2024
4:00 PM | Catalyst Pharmaceuticals (Issuer)
DENKHAUS DONALD A (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/31/2024
4:01 PM | Catalyst Pharmaceuticals (Issuer)
MCENANY PATRICK J (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/25/2024
9:09 AM | Catalyst Pharmaceuticals (Subject)
STATE STREET CORP (Filed by)
| Form SC 13G/A | |
01/09/2024
4:15 PM | Catalyst Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/08/2024
7:10 AM | Catalyst Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/05/2024
4:23 PM | Catalyst Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/05/2024
4:15 PM | Catalyst Pharmaceuticals (Filer)
| Form 424B5 | |
01/03/2024
4:18 PM | Catalyst Pharmaceuticals (Issuer)
Kalb Michael Wayne (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
01/03/2024
4:18 PM | Catalyst Pharmaceuticals (Issuer)
Daly Richard J (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/03/2024
4:18 PM | Catalyst Pharmaceuticals (Issuer)
O'Keeffe Charles B (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/03/2024
4:19 PM | Catalyst Pharmaceuticals (Issuer)
Tierney David S (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/03/2024
4:19 PM | Catalyst Pharmaceuticals (Issuer)
MCENANY PATRICK J (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/29/2023
4:00 PM | Catalyst Pharmaceuticals (Issuer)
DENKHAUS DONALD A (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/29/2023
4:00 PM | Catalyst Pharmaceuticals (Issuer)
MCENANY PATRICK J (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/29/2023
4:00 PM | Catalyst Pharmaceuticals (Issuer)
Miller Steve (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/29/2023
4:00 PM | Catalyst Pharmaceuticals (Issuer)
GRANDE ALICIA (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/29/2023
4:00 PM | Catalyst Pharmaceuticals (Issuer)
INGENITO GARY (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/29/2023
4:00 PM | Catalyst Pharmaceuticals (Issuer)
Daly Richard J (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/29/2023
4:00 PM | Catalyst Pharmaceuticals (Issuer)
Del Carmen Jeffrey (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
Why I'm telling friends to avoid gold stocks (Ad) Back in November, gold made a tiny move of 1.6%.
But according to my backtesting by using a special type of gold trade, I would have seen a 141% gain in just a week.
It happened again in March. Gold nudged up 1.2%.
This time? A 104% overnight gain.
And in June? A 1% gold move turned into a 74% gain in two weeks.
Granted, there would have been smaller wins and those that did not work out, but you see, there's a reason I'm telling all my friends to hold off from buying gold or regular gold stocks right now.
There's a more lucrative way to play the gold market as we enter a new breakout period.
It's all about catching what I call "Acceleration Cycles." And if you’d like to get your hands on this, here you go, the complete breakdown. |
12/29/2023
4:00 PM | Catalyst Pharmaceuticals (Issuer)
Tierney David S (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/29/2023
4:00 PM | Catalyst Pharmaceuticals (Issuer)
Harper Molly (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/29/2023
4:00 PM | Catalyst Pharmaceuticals (Issuer)
Sundaram Preethi (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/29/2023
4:00 PM | Catalyst Pharmaceuticals (Issuer)
O'Keeffe Charles B (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/29/2023
4:00 PM | Catalyst Pharmaceuticals (Issuer)
Elsbernd Brian (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
